Lily Lee

Lily Lee has extensive work experience in the pharmaceutical and biotechnology industry. Lily is currently the Vice President and Head of Medical Affairs at TG Therapeutics, Inc. starting in January 2023. Prior to this role, they were the Executive Director and Disease Area Head for Immunology at TG Therapeutics from April 2021 to December 2022.

Before joining TG Therapeutics, Lily worked at Arena Pharmaceuticals, Inc. as the Senior Director and Medical Value Team Lead for Global Medical Affairs from November 2019 to April 2021.

Lily also held various positions at Biogen, starting as a Senior Medical Science Liaison for Neurology from September 2010 to June 2015. Lily then became an Associate Medical Director for Neurology for Tysabri from June 2015 to March 2017, and later served as the Medical Director for Neurology and the US Tysabri Lead from March 2017 to November 2019.

Prior to their time at Biogen, Lily worked at Shire as a Senior Medical Science Liaison for GI from April 2007 to August 2010. Lily also gained experience as a Senior Scientist at Johnson & Johnson from June 2001 to March 2007.

Lily began their career at Provid Research as a Scientists II from February 1999 to March 2001. Throughout their various roles and companies, Lily has built a strong background in medical affairs, specifically in the fields of immunology, neurology, and gastrointestinal medicine.

Lily Lee holds a Doctor of Philosophy (PhD) degree in Organic Chemistry from Boston University. No additional information is available regarding the start or end year of this educational experience.